BCD-022 with paclitaxel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCD-022 with paclitaxel, covering 2016-10-24 to 2016-10-24. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients [Phase 3]